Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Selectis Health (GBCS) Consolidated Net Income (2017 - 2025)

Historic Consolidated Net Income for Selectis Health (GBCS) over the last 14 years, with Q3 2025 value amounting to -$502660.0.

  • Selectis Health's Consolidated Net Income rose 6947.83% to -$502660.0 in Q3 2025 from the same period last year, while for Sep 2025 it was -$2.6 million, marking a year-over-year increase of 6753.07%. This contributed to the annual value of -$4.8 million for FY2024, which is 5710.43% up from last year.
  • Per Selectis Health's latest filing, its Consolidated Net Income stood at -$502660.0 for Q3 2025, which was up 6947.83% from -$676280.0 recorded in Q2 2025.
  • In the past 5 years, Selectis Health's Consolidated Net Income ranged from a high of $987560.0 in Q2 2022 and a low of -$3.7 million during Q4 2023
  • For the 5-year period, Selectis Health's Consolidated Net Income averaged around -$1.2 million, with its median value being -$1.0 million (2022).
  • Its Consolidated Net Income has fluctuated over the past 5 years, first tumbled by 145162.32% in 2021, then skyrocketed by 25237.35% in 2022.
  • Selectis Health's Consolidated Net Income (Quarter) stood at -$2.0 million in 2021, then dropped by 12.4% to -$2.2 million in 2022, then plummeted by 65.07% to -$3.7 million in 2023, then skyrocketed by 87.67% to -$452978.0 in 2024, then dropped by 10.97% to -$502660.0 in 2025.
  • Its Consolidated Net Income was -$502660.0 in Q3 2025, compared to -$676280.0 in Q2 2025 and -$964413.0 in Q1 2025.